(NYSE: CHE) Chemed's forecast annual revenue growth rate of 6.43% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.61%.
Chemed's revenue in 2026 is $2,529,978,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $37,110,806,656, with the lowest CHE revenue forecast at $35,954,535,232, and the highest CHE revenue forecast at $38,652,501,888. On average, 5 Wall Street analysts forecast CHE's revenue for 2027 to be $39,423,349,504, with the lowest CHE revenue forecast at $37,744,002,912, and the highest CHE revenue forecast at $41,584,475,856.
In 2028, CHE is forecast to generate $41,818,483,168 in revenue, with the lowest revenue forecast at $40,579,620,928 and the highest revenue forecast at $43,484,064,624.